A multi-omics approach to reveal critical mechanisms of activator protein 1 (AP-1)

被引:3
|
作者
Li, Fei [1 ,2 ]
Tian, Jiaqi [1 ]
Zhang, Lin [1 ]
He, Huan [3 ]
Song, Dandan [1 ]
机构
[1] Qingdao Univ, Shandong Prov Maternal & Child Hlth Care Hosp, Key Lab Birth Defect Prevent & Genet Med Shandong, Clin Med Res Ctr Women & Children Dis,Key Lab Birt, Jinan 250014, Peoples R China
[2] North China Univ Sci & Technol, Sch Publ Hlth, Tangshan 063000, Peoples R China
[3] Jilin Univ, Sch Publ Hlth, NHC Key Lab Radiobiol, Changchun 130021, Peoples R China
关键词
AP-1; Jun; Fos; Multi-omics; Cancer; TRANSCRIPTION FACTOR; DNA METHYLATION; BREAST-CANCER; VIRUS; EXPRESSION; SEQ; OVEREXPRESSION; REPLICATION; INSIGHTS;
D O I
10.1016/j.biopha.2024.117225
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The Activator Protein 1 (AP-1) transcription factor complex plays a pivotal role in the regulation of cancer- related genes, influencing cancer cell proliferation, invasion, migration, angiogenesis, and apoptosis. Composed of multiple subunits, AP-1 has diverse roles across different cancer types and environmental contexts, but its specific mechanisms remain unclear. The advent of multi-omics approaches has shed light on a more comprehensive understanding of AP-1's role and mechanism in gene regulation. This review collates recent genome-wide data on AP-1 and provides an overview of its expression, structure, function, and interaction across different diseases. An examination of these findings can illuminate the intricate nature of AP-1 regulation and its significant involvement in the progression of different diseases. Moreover, we discuss the potential use of AP-1 as a target for individual therapy and explore the various challenges associated with such an approach. Ultimately, this review provides valuable insights into the biology of AP-1 and its potential as a therapeutic target for cancer and disease treatments.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] The potential of activator protein 1 (AP-1) in cancer targeted therapy
    Song, Dandan
    Lian, Yan
    Zhang, Lin
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [2] Towards dissecting the complexity of the AP-1 (Activator Protein 1) family
    Unal, R
    Weih, F
    Schorle, H
    Herrlich, P
    BIOMATERIALS: FROM MOLECULES TO ENGINEERED TISSUES, 2004, 553 : 331 - 336
  • [3] Small Molecule Inhibitors Targeting Activator Protein 1 (AP-1)
    Ye, Na
    Ding, Ye
    Wild, Christopher
    Shen, Qiang
    Zhou, Jia
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (16) : 6930 - 6948
  • [4] Role of activator protein-1 (AP-1) in endothelial cell activation
    Wang, NP
    Verna, L
    Hardy, S
    Zhu, Y
    Stemerman, MB
    CIRCULATION, 1998, 98 (17) : 316 - 316
  • [5] Multi-omics studies reveal genes critical for AKI and ferroptosis
    Sakashita, Midori
    Nangaku, Masaomi
    KIDNEY INTERNATIONAL, 2022, 101 (04) : 665 - 667
  • [6] Multi-omics computational analysis unveils the involvement of AP-1 and CTCF in hysteresis of chromatin states during macrophage polarization
    Zhang, Yubo
    Yang, Wenbo
    Kumagai, Yutaro
    Loza, Martin
    Zhang, Weihang
    Park, Sung-Joon
    Nakai, Kenta
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] Expression of activator protein-1 (AP-1) family members in breast cancer
    Kharman-Biz, Amirhossein
    Gao, Hui
    Ghiasvand, Reza
    Zhao, Chunyan
    Zendehdel, Kazem
    Dahlman-Wright, Karin
    BMC CANCER, 2013, 13
  • [9] Expression of activator protein-1 (AP-1) family members in breast cancer
    Amirhossein Kharman-Biz
    Hui Gao
    Reza Ghiasvand
    Chunyan Zhao
    Kazem Zendehdel
    Karin Dahlman-Wright
    BMC Cancer, 13
  • [10] A multi-omics approach to understand the underlying mechanisms of obesity
    Niu, J.
    Gieger, C.
    Peters, A.
    Sharma, S.
    Grallert, H.
    DIABETOLOGIA, 2024, 67 : S108 - S108